Concord Medical Net Worth
Concord Medical Net Worth Breakdown | CCM |
Concord Medical Net Worth Analysis
Concord Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Concord Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Concord Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Concord Medical's net worth analysis. One common approach is to calculate Concord Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Concord Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Concord Medical's net worth. This approach calculates the present value of Concord Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Concord Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Concord Medical's net worth. This involves comparing Concord Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Concord Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Concord Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Concord Medical's net worth research are outlined below:
| Concord Medical had very high historical volatility over the last 90 days | |
| Concord Medical has high likelihood to experience some financial distress in the next 2 years | |
| Concord Medical Services has 3.3 B in debt with debt to equity (D/E) ratio of 1.25, which is OK given its current industry classification. Concord Medical Services has a current ratio of 0.7, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Concord to invest in growth at high rates of return. | |
| The entity reported the last year's revenue of 537.4 M. Reported Net Loss for the year was (531.02 M) with loss before taxes, overhead, and interest of (152.41 M). | |
| Concord Medical Services has about 157.39 M in cash with (276.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72. | |
| Concord Medical has a poor financial position based on the latest SEC disclosures | |
| Roughly 18.0% of Concord Medical shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Enterprise Financial Services Q3 Earnings and Revenues Top Estimates |
Concord Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Concord Medical Services. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Concord Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 17th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Know Concord Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Concord Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Concord Medical Services backward and forwards among themselves. Concord Medical's institutional investor refers to the entity that pools money to purchase Concord Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-03-31 | 40.7 K | Rhumbline Advisers | 2024-03-31 | 5.5 K | Blackrock Inc | 2024-03-31 | 0.0 | Bank Of America Corp | 2024-06-30 | 0.0 | Ubs Group Ag | 2024-03-31 | 0.0 |
Follow Concord Medical's market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 34.72 M.Market Cap |
|
Project Concord Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.06) | (0.07) | |
| Return On Capital Employed | (0.11) | (0.11) | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | 0.14 | 0.27 |
When accessing Concord Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Concord Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Concord Medical's profitability and make more informed investment decisions.
Evaluate Concord Medical's management efficiency
Concord Medical Services has Return on Asset of (0.044) % which means that on every $100 spent on assets, it lost $0.044. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.324) %, meaning that it generated no profit with money invested by stockholders. Concord Medical's management efficiency ratios could be used to measure how well Concord Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 24th of October 2024, Return On Equity is likely to grow to 0.27, while Return On Tangible Assets are likely to drop (0.07). At this time, Concord Medical's Other Current Assets are very stable compared to the past year. As of the 24th of October 2024, Total Current Assets is likely to grow to about 736.9 M, while Other Assets are likely to drop about 26.2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 399.91 | 251.57 | |
| Tangible Book Value Per Share | 103.11 | 146.81 | |
| Enterprise Value Over EBITDA | (11.46) | (10.88) | |
| Price Book Value Ratio | (0.17) | (0.16) | |
| Enterprise Value Multiple | (11.46) | (10.88) | |
| Price Fair Value | (0.17) | (0.16) | |
| Enterprise Value | 3.6 B | 6.9 B |
Concord Medical showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Enterprise Value Revenue 7.3796 | Revenue 471.7 M | Quarterly Revenue Growth (0.23) | Revenue Per Share 107.978 | Return On Equity (0.32) |
Concord Medical Corporate Filings
6K | 27th of September 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 11th of July 2024 Other Reports | ViewVerify | |
| 19th of April 2024 Other Reports | ViewVerify |
Concord Medical Earnings per Share Projection vs Actual
Concord Medical Corporate Management
| Xun Liu | Financial Controller | Profile | |
| Qing Pan | Director | Profile | |
| Matthew Callister | Chief Medical Officer | Profile | |
| Boxun Zhang | Independent Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (12.21) | Revenue Per Share 107.978 | Quarterly Revenue Growth (0.23) | Return On Assets (0.04) | Return On Equity (0.32) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.